Cargando…

Psilocybin-assisted therapy for reducing alcohol intake in patients with alcohol use disorder: protocol for a randomised, double-blinded, placebo-controlled 12-week clinical trial (The QUANTUM Trip Trial)

INTRODUCTION: Alcohol use disorder is a difficult-to-treat psychiatric disorder and a major burden on public health. Existing treatment efficacy is moderate, and relapse rates are high. Preliminary findings suggest that psilocybin, a psychedelic compound, can safely and reliably occasion highly mean...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jensen, Mathias Ebbesen, Stenbæk, Dea Siggaard, Juul, Tobias Søgaard, Fisher, Patrick MacDonald, Ekstrøm, Claus Thorn, Knudsen, Gitte Moos, Fink-Jensen, Anders
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2022
Materias:	Mental Health
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577917/ https://www.ncbi.nlm.nih.gov/pubmed/36241352 http://dx.doi.org/10.1136/bmjopen-2022-066019

Ejemplares similares

Lasting increases in trait mindfulness after psilocybin correlate positively with the mystical-type experience in healthy individuals
por: Søndergaard, Anna, et al.
Publicado: (2022)

Lasting effects of a single psilocybin dose on resting-state functional connectivity in healthy individuals
por: McCulloch, Drummond E-Wen, et al.
Publicado: (2021)

Psilocybin-Induced Mystical-Type Experiences are Related to Persisting Positive Effects: A Quantitative and Qualitative Report
por: McCulloch, Drummond E-Wen, et al.
Publicado: (2022)

Cognitive impairment and psychopathology in out-of-hospital cardiac arrest survivors in Denmark: The REVIVAL cohort study protocol
por: Wagner, Mette Kirstine, et al.
Publicado: (2020)

Subacute effects of a single dose of psilocybin on biomarkers of inflammation in healthy humans: An open-label preliminary investigation
por: Burmester, Daniel Rødbro, et al.
Publicado: (2022)

Exenatide once weekly for alcohol use disorder investigated in a randomized, placebo-controlled clinical trial
por: Klausen, Mette Kruse, et al.
Publicado: (2022)

Music programming for psilocybin-assisted therapy: Guided Imagery and Music-informed perspectives
por: Messell, Catharina, et al.
Publicado: (2022)

Exercise as adjunctive treatment for alcohol use disorder: A randomized controlled trial
por: Roessler, Kirsten K., et al.
Publicado: (2017)

Short-term oestrogen as a strategy to prevent postpartum depression in high-risk women: protocol for the double-blind, randomised, placebo-controlled MAMA clinical trial
por: Høgh, Stinne, et al.
Publicado: (2021)

Trait aggression is associated with five‐factor personality traits in males
por: Dam, Vibeke H., et al.
Publicado: (2021)

Does glucagon-like peptide-1 (GLP-1) receptor agonist stimulation reduce alcohol intake in patients with alcohol dependence: study protocol of a randomised, double-blinded, placebo-controlled clinical trial
por: Antonsen, Kerstin K, et al.
Publicado: (2018)

Evaluating cognitive disturbances as treatment target and predictor of antidepressant action in major depressive disorder: A NeuroPharm study
por: Dam, Vibeke Høyrup, et al.
Publicado: (2022)

Psilocybin-assisted therapy for the treatment of resistant major depressive disorder (PsiDeR): protocol for a randomised, placebo-controlled feasibility trial
por: Rucker, James, et al.
Publicado: (2021)

Acute and long-term effects of psilocybin on energy balance and feeding behavior in mice
por: Fadahunsi, Nicole, et al.
Publicado: (2022)

Predicting Treatment Outcome in Major Depressive Disorder Using Serotonin 4 Receptor PET Brain Imaging, Functional MRI, Cognitive-, EEG-Based, and Peripheral Biomarkers: A NeuroPharm Open Label Clinical Trial Protocol
por: Köhler-Forsberg, Kristin, et al.
Publicado: (2020)

Clinical Interpretations of Patient Experience in a Trial of Psilocybin-Assisted Psychotherapy for Alcohol Use Disorder
por: Bogenschutz, Michael P., et al.
Publicado: (2018)

Effect of the GLP-1 receptor agonist semaglutide on metabolic disturbances in clozapine-treated or olanzapine-treated patients with a schizophrenia spectrum disorder: study protocol of a placebo-controlled, randomised clinical trial (SemaPsychiatry)
por: Sass, Marie Reeberg, et al.
Publicado: (2023)

A Single Dose of Psilocybin Increases Synaptic Density and Decreases 5-HT(2A) Receptor Density in the Pig Brain
por: Raval, Nakul Ravi, et al.
Publicado: (2021)

Editorial: The psychotherapeutic framing of psychedelic drug administration
por: Beckman, Maria, et al.
Publicado: (2023)

Community-based alcohol education intervention (THEATRE) study to reduce harmful effects of alcohol in rural Sri Lanka: design and adaptation of a mixed-methods stepped wedge cluster randomised control trial
por: Pearson, Melissa, et al.
Publicado: (2023)

The Bipolar Illness Onset study: research protocol for the BIO cohort study
por: Kessing, Lars Vedel, et al.
Publicado: (2017)

Outpatient treatment of alcohol use disorders among subjects 60+ years: design of a randomized clinical trial conducted in three countries (Elderly Study)
por: Andersen, Kjeld, et al.
Publicado: (2015)

Psychometric Properties of the Verbal Affective Memory Test-26 and Evaluation of Affective Biases in Major Depressive Disorder
por: Hjordt, Liv V., et al.
Publicado: (2020)

Psilocybin targets a common molecular mechanism for cognitive impairment and increased craving in alcoholism
por: Meinhardt, Marcus W., et al.
Publicado: (2021)

The effectiveness of mindfulness-based stress reduction for school teachers: a cluster-randomized controlled trial
por: Bonde, Emilie H, et al.
Publicado: (2022)

Default mode network functional connectivity negatively associated with trait openness to experience
por: Marstrand-Joergensen, Maja Rou, et al.
Publicado: (2021)

No evidence for a role of the serotonin 4 receptor in five-factor personality traits: A positron emission tomography brain study
por: Stenbæk, Dea Siggaard, et al.
Publicado: (2017)

Psilocybin sex-dependently reduces alcohol consumption in C57BL/6J mice
por: Alper, Kenneth, et al.
Publicado: (2023)

Combining online Community Reinforcement and Family Training (CRAFT) with a parent-training programme for parents with partners suffering from alcohol use disorder: study protocol for a randomised controlled trial
por: Lindner, Philip, et al.
Publicado: (2018)

Cognitive–behavioural group therapy for adolescents with ADHD: study protocol for a randomised controlled trial
por: Nøvik, Torunn Stene, et al.
Publicado: (2020)

Having a ball: evaluating scoring streaks and game excitement using in-match trend estimation
por: Ekstrøm, Claus Thorn, et al.
Publicado: (2022)

Calibrating the Alcohol Use Disorders Identification Test-Consumption (AUDIT-C) for detecting alcohol-related problems among Canadian, UK and US soldiers: cross-sectional pre-deployment and post-deployment survey results
por: Duffy, Farifteh Firoozmand, et al.
Publicado: (2023)

Epidemiological features of alcohol use in rural India: a population-based cross-sectional study
por: Rathod, Sujit D, et al.
Publicado: (2015)

Psychosocial workplace factors and alcohol-related morbidity: a prospective study of 3 million Swedish workers
por: Almroth, Melody, et al.
Publicado: (2022)

Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder: A Randomized Clinical Trial
por: Bogenschutz, Michael P., et al.
Publicado: (2022)

Third-wave cognitive therapy versus mentalisation-based treatment for major depressive disorder: a randomised clinical trial
por: Jakobsen, Janus Christian, et al.
Publicado: (2014)

Brain serotonin transporter is associated with cognitive‐affective biases in healthy individuals
por: Armand, Sophia, et al.
Publicado: (2022)

Changes in alcohol consumption after treatment for depression: a secondary analysis of the Swedish randomised controlled study REGASSA
por: Strid, Catharina, et al.
Publicado: (2019)

Nature-themed video intervention may improve cardiovascular safety of psilocybin-assisted therapy for alcohol use disorder
por: Heinzerling, Keith G., et al.
Publicado: (2023)

SARS-CoV-2 seroprevalence among patients with severe mental illness: A cross-sectional study
por: Sass, Marie Reeberg, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0gmtl5i9hijbo4akhuvsdmub71